HK1067984A1 - Compositions comprising ipatropium and xylometazoline for treatment of the common cold - Google Patents

Compositions comprising ipatropium and xylometazoline for treatment of the common cold

Info

Publication number
HK1067984A1
HK1067984A1 HK05101053A HK05101053A HK1067984A1 HK 1067984 A1 HK1067984 A1 HK 1067984A1 HK 05101053 A HK05101053 A HK 05101053A HK 05101053 A HK05101053 A HK 05101053A HK 1067984 A1 HK1067984 A1 HK 1067984A1
Authority
HK
Hong Kong
Prior art keywords
compositions
common cold
xylometazoline
ipatropium
treatment
Prior art date
Application number
HK05101053A
Other languages
English (en)
Inventor
Hanne Anette Moesgaard
Karin Lowenstein Christensen
Original Assignee
Nycomed Danmark Aps
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nycomed Danmark Aps filed Critical Nycomed Danmark Aps
Publication of HK1067984A1 publication Critical patent/HK1067984A1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/46—8-Azabicyclo [3.2.1] octane; Derivatives thereof, e.g. atropine, cocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/02—Nasal agents, e.g. decongestants

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Emergency Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Otolaryngology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Saccharide Compounds (AREA)
  • Orthopedics, Nursing, And Contraception (AREA)
  • Treatments For Attaching Organic Compounds To Fibrous Goods (AREA)
  • Polyurethanes Or Polyureas (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Cosmetics (AREA)
HK05101053A 2001-09-18 2005-02-07 Compositions comprising ipatropium and xylometazoline for treatment of the common cold HK1067984A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DKPA200101356 2001-09-18
PCT/IB2002/003828 WO2003024433A2 (en) 2001-09-18 2002-09-18 Compositions for treatment of common cold, comprising ipratropium and xylometazoline

Publications (1)

Publication Number Publication Date
HK1067984A1 true HK1067984A1 (en) 2005-04-22

Family

ID=8160714

Family Applications (1)

Application Number Title Priority Date Filing Date
HK05101053A HK1067984A1 (en) 2001-09-18 2005-02-07 Compositions comprising ipatropium and xylometazoline for treatment of the common cold

Country Status (21)

Country Link
US (2) US7652030B2 (xx)
EP (2) EP1446119B1 (xx)
JP (1) JP4500045B2 (xx)
KR (1) KR100810872B1 (xx)
CN (1) CN1290502C (xx)
AT (1) ATE318601T1 (xx)
BR (1) BRPI0212586B8 (xx)
CA (1) CA2460140C (xx)
DE (1) DE60209511T2 (xx)
DK (1) DK1446119T3 (xx)
EA (1) EA008165B1 (xx)
ES (1) ES2259098T3 (xx)
HK (1) HK1067984A1 (xx)
HU (1) HU226527B1 (xx)
MX (1) MXPA04002500A (xx)
NO (1) NO334441B1 (xx)
NZ (1) NZ531792A (xx)
PL (1) PL208686B1 (xx)
PT (1) PT1446119E (xx)
SI (1) SI1446119T1 (xx)
WO (1) WO2003024433A2 (xx)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030055026A1 (en) 2001-04-17 2003-03-20 Dey L.P. Formoterol/steroid bronchodilating compositions and methods of use thereof
EP1446119B1 (en) * 2001-09-18 2006-03-01 Nycomed Danmark ApS Compositions comprising ipatropium and xylometazoline for treatment of the common cold
TWI359675B (en) * 2003-07-10 2012-03-11 Dey L P Bronchodilating β-agonist compositions
CN1913882A (zh) * 2004-02-06 2007-02-14 Meda制药有限及两合公司 用抗胆碱能药单独或联合抗组胺药、磷酸二酯酶4抑制剂或皮质类固醇来治疗鼻炎
WO2005084330A2 (en) * 2004-03-02 2005-09-15 Synergia Pharma, Inc. Compositions and methods for treating nasal congestion
DE102004049008A1 (de) * 2004-10-05 2006-04-06 Merck Patent Gmbh Neue Verwendung für α-Sympathomimetika mit 2-Imidazolinstruktur
MX2007007836A (es) * 2004-12-27 2007-08-20 Eisai R&D Man Co Ltd Metodo para estabilizar un farmaco anti-demencia.
DE102006023770A1 (de) * 2006-05-20 2007-11-22 Boehringer Ingelheim Pharma Gmbh & Co. Kg Treibgasfreie Aerosolformulierung für die Inhalation
EP2077132A1 (en) 2008-01-02 2009-07-08 Boehringer Ingelheim Pharma GmbH & Co. KG Dispensing device, storage device and method for dispensing a formulation
US20090270472A1 (en) * 2008-04-25 2009-10-29 Kenneth Gould Method to use oxymetazoline to interrupt the development of the common cold syndrome
EP2662472B1 (de) 2009-03-31 2019-02-27 Boehringer Ingelheim International Gmbh Verfahren zur Beschichtung einer Oberfläche eines Bauteils
US9265910B2 (en) 2009-05-18 2016-02-23 Boehringer Ingelheim International Gmbh Adapter, inhalation device, and nebulizer
UA107097C2 (xx) 2009-11-25 2014-11-25 Бьорінгер Інгельхайм Інтернаціональ Гмбх Розпилювач
WO2011064163A1 (en) 2009-11-25 2011-06-03 Boehringer Ingelheim International Gmbh Nebulizer
US10016568B2 (en) 2009-11-25 2018-07-10 Boehringer Ingelheim International Gmbh Nebulizer
JP5874724B2 (ja) 2010-06-24 2016-03-02 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング ネブライザ
EP2694220B1 (de) 2011-04-01 2020-05-06 Boehringer Ingelheim International GmbH Medizinisches gerät mit behälter
US9827384B2 (en) 2011-05-23 2017-11-28 Boehringer Ingelheim International Gmbh Nebulizer
WO2013152894A1 (de) 2012-04-13 2013-10-17 Boehringer Ingelheim International Gmbh Zerstäuber mit kodiermitteln
WO2014158118A1 (en) * 2013-03-29 2014-10-02 Santa Farma İlaç Sanayi̇ A.Ş. Suspension composition containing ipratropium and oxymetazoline
EP2978407B1 (en) * 2013-03-29 2020-05-06 Santa Farma Ilaç Sanayi A.S. Aqueous solution composition containing ipratropium and oxymetazoline
JP6643231B2 (ja) 2013-08-09 2020-02-12 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング ネブライザ
EP2835146B1 (en) 2013-08-09 2020-09-30 Boehringer Ingelheim International GmbH Nebulizer
WO2015054359A1 (en) * 2013-10-08 2015-04-16 Ebadi Mark A Methods and compositions for symptomatic reflief of the common cold
HUE055604T2 (hu) 2014-05-07 2021-12-28 Boehringer Ingelheim Int Porlasztó
DK3139983T3 (da) 2014-05-07 2023-09-11 Boehringer Ingelheim Int Beholder og indikatoranordning, samt forstøver
JP6580070B2 (ja) 2014-05-07 2019-09-25 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング 容器、ネブライザ、及び使用
EP3236933B1 (en) * 2014-12-24 2018-11-14 JADRAN - GALENSKI LABORATORIJ d.d. A nasal composition containing sea water as stability-improving excipient
MX2015016549A (es) * 2015-12-02 2017-06-01 Cortés Borrego Pablo Combinacion de oximetazolina e ipratropio en aplicacion topica nasal para el tratamiento de la tos.
US20220031739A1 (en) * 2020-07-31 2022-02-03 Eye Therapies Llc Anti-viral compositions and methods of use thereof

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2137981T3 (es) 1991-11-19 2000-01-01 Univ Virginia Tratamiento combinado por agentes antimediaticos y antiviricos de resfriados comunes.
IL101056A (en) * 1992-02-24 1997-03-18 Res & Dev Co Ltd Composition for nasal treatment
GB9218834D0 (en) 1992-09-05 1992-10-21 Procter & Gamble Nasal spray products
AU680227B2 (en) 1992-12-09 1997-07-24 Boehringer Ingelheim Pharmaceuticals, Inc. Stabilized medicinal aerosol solution formulations
EP0780127A1 (en) 1995-12-19 1997-06-25 The Procter & Gamble Company A nasal spray containing a steroid and a antihistamine
DE19653969A1 (de) * 1996-12-20 1998-06-25 Boehringer Ingelheim Kg Neue wässrige Arzneimittelzubereitung zur Erzeugung treibgasfreier Aerosole
IL131492A0 (en) 1997-04-30 2001-01-28 Warner Lambert Co Topical nasal antiinflammatory compositions
AU741364B2 (en) * 1998-01-30 2001-11-29 Novartis Consumer Health S.A. Nasal solutions
PL193695B1 (pl) 1998-06-18 2007-03-30 Boehringer Ingelheim Pharma Preparat farmaceutyczny do napędzanych propelentem inhalatorów zawierający połączenie dwóch lub więcej substancji aktywnych oraz jego zastosowanie
CA2376121C (en) * 1999-06-22 2008-06-10 Boehringer Ingelheim International Gmbh Stable xylometazoline and oxymetazoline solution
EP1446119B1 (en) * 2001-09-18 2006-03-01 Nycomed Danmark ApS Compositions comprising ipatropium and xylometazoline for treatment of the common cold

Also Published As

Publication number Publication date
CA2460140C (en) 2009-09-01
DK1446119T3 (da) 2006-07-10
WO2003024433A2 (en) 2003-03-27
NZ531792A (en) 2006-02-24
DE60209511T2 (de) 2006-10-05
HUP0402075A3 (en) 2008-04-28
EP1661570A3 (en) 2012-10-24
KR100810872B1 (ko) 2008-03-06
EP1661570A2 (en) 2006-05-31
PT1446119E (pt) 2006-07-31
EP1446119B1 (en) 2006-03-01
WO2003024433A3 (en) 2004-06-10
KR20040049849A (ko) 2004-06-12
PL208686B1 (pl) 2011-05-31
MXPA04002500A (es) 2004-11-22
EP1446119A2 (en) 2004-08-18
US8450339B2 (en) 2013-05-28
JP2005505569A (ja) 2005-02-24
US20100093783A1 (en) 2010-04-15
EA200400444A1 (ru) 2005-02-24
US7652030B2 (en) 2010-01-26
US20040248924A1 (en) 2004-12-09
DE60209511D1 (de) 2006-04-27
NO334441B1 (no) 2014-03-03
ATE318601T1 (de) 2006-03-15
CN1290502C (zh) 2006-12-20
SI1446119T1 (sl) 2006-08-31
BRPI0212586B8 (pt) 2021-05-25
PL370536A1 (en) 2005-05-30
JP4500045B2 (ja) 2010-07-14
BR0212586B1 (pt) 2013-11-19
HU226527B1 (hu) 2009-03-30
BR0212586A (pt) 2004-10-13
EA008165B1 (ru) 2007-04-27
CN1555263A (zh) 2004-12-15
HUP0402075A2 (hu) 2005-02-28
CA2460140A1 (en) 2003-03-27
ES2259098T3 (es) 2006-09-16
NO20041070L (no) 2004-05-18

Similar Documents

Publication Publication Date Title
HK1067984A1 (en) Compositions comprising ipatropium and xylometazoline for treatment of the common cold
JO2311B1 (en) Alkyl inhibitors Ariel phosphodiesterase-4
BR9812361A (pt) Uso de combinações compreendendo anti-histaminas não-sedantes e drogas alfa-adrenérgicas para o tratamento tópico de rinite/conjutivite e sintomas de infecção por vìrus, semelhante a infecção por vìrus e/ou resfriado
MXPA04005865A (es) Suministro de aminoglucosidos a los pulmones.
WO2002085909A8 (en) 9-deazaguanine derivatives as inhibitors of gsk-3
HK1057330A1 (en) Use of hydroxyethylrutosides for treating symptomsof common cold, allergic rhinitis and infections relating to the respiratory tract
MXPA04002825A (es) Derivados de quinolina como antagonistas de neuropeptido y.
WO2002070510A3 (de) Aminodicarbonsäurederivate mit pharmazeutischen eigenschaften
WO2006044362A3 (en) N-sulfonylpiperidine cannabinoid receptor 1 antagonists
WO2001066564A3 (en) Gamma-secretase inhibitors
TW200504078A (en) Therapeutically active compounds and their use
SG152257A1 (en) Topical preparation containing ambroxol
MXPA03010761A (es) Combinaciones farmaceuticas.
AU2002307049A1 (en) Use of mglur5 antagonists in the manufacture of a medicament in the treatment of autism, mental retardation, schizophrenia
WO2003087049A3 (de) Arzneimittelkombinationen enthaltend heterocyclische verbindungen und ein neues anticholinergikum
DE60322417D1 (en) 4-oxo-1-(3-substituiertesphenyl)-1,4-dihydro-1,8-naphthyridin-3-carbonsäureamide alsphoshodiesterase-4-inhibitoren
WO2002072584A3 (en) Tetrahydro-pyrazino (1,2-a) indoles for the treatment of central nervous disorders
ATE303384T1 (de) 1-biaryl-1,8-naphthyridin-4-one als phosphodieseterase-inhibitoren
MXPA03011466A (es) Macrociclos utiles en tratamiento de enfermedades de alzheimer.
WO2004082706A3 (en) Ifn-beta alone or in combination with other medicaments for treating alzheimer's disease and demens disorders
WO2002072571A8 (en) Pyridinyl pyrazoles useful for the treatment of copd
WO2003032985A3 (en) Concomitant oral and topical administration of anti - infective agents
BR0212329A (pt) Métodos para tratar doença pulmonar
CA2436511A1 (en) Use of flumazenil to produce a medicament for the treatment of cocaine dependency
WO2005039483A3 (en) Anti-inflammatory pharmaceutical compositions for reducing inflammation and the treatment or prevention of gastric toxicity

Legal Events

Date Code Title Description
PE Patent expired

Effective date: 20220917